Elekta to distribute C-RAD SIGRT technology in North America and Mexico
advertisement
Aktueller Standort:
>
> This Story


Log in oder Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

MD Anderson to expand proton therapy center with $159 million project Increases accessibility to higher number of patients

Radiotherapy beats anti-hormonal therapy for some breast cancer patients, says study Avoiding side effects such as hot flashes, weight gain and bone fracture

New technique may concentrate radiotherapy dose for minimal tissue damage Utilizes very high energy electrons (VHEEs)

MedAustron delivers first bout of carbon ion therapy on patient Sixth center in the world to offer treatment

Research shows how hurricanes hinder radiotherapy outcomes Treatment transfers and eliminating out-of-network insurance charges could help

CMS proposes alternative payment model for radiation oncology Uses prospective, episode-based payments; ensures value-based care

FDA gives RaySearch green light for RayStation 8B platform First treatment planning system to offer machine learning applications

MedAustron to add health IT to proton and carbon ion treatment facilities Orders more than $13 million worth of RaySearch systems

'Nudge' in EHRs cuts imaging in half for palliative radiotherapy, says study Reduces duration of radiotherapy sessions

Mayo Clinic Florida campus to get $233 million proton facility The 140,000-square-foot facility will house a two-gantry proton system

Elekta can now distribute C-RAD's
Catalyst HD solution, which can
integrate with linacs like
the Versa HD

Elekta to distribute C-RAD SIGRT technology in North America and Mexico

by John R. Fischer , Staff Reporter
C-RAD has granted Elekta the right to distribute its surface image-guided radiation therapy (SIGRT) technology to providers for use in stereotactic radiosurgery, stereotactic body radiotherapy, and motion management.

Beginning in the North American and Mexican markets, the agreement brings together the benefits of C-RAD’s Catalyst HD system, which integrates with Elekta linacs, and those of Elekta’s Versa HD high-definition dynamic radiosurgery solution.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



"Accuracy is key when escalating dose," Dee Mathieson, senior vice president of treatment solutions at Elekta, told HCB News. "The X-ray products complement the patient set up and motion management capabilities of the Versa HD to give confidence to the clinicians."

A non-surgical treatment, stereotactic radiotherapy is used to treat functional abnormalities and small tumors within the brain. Stereotactic body radiotherapy is used to treat the same issues within the body.

Capable of treating all parts and organs in the body, Versa HD customizes high-energy X-rays to conform to a tumor’s shape and destroy cancer cells while sparing surrounding healthy tissue.

In addition to providing gross patient positioning and postural positioning, the Catalyst system is equipped with respiratory motion management and other capabilities that extend the value of Elekta’s Versa HD system.

“Our priority is always to provide a high level of patient safety and comfort while ensuring an efficient and seamless workflow for clinicians with the greatest degree of confidence,” said Maurits Wolleswinkel, president of linac solutions at Elekta, in a statement. This collaboration with C-RAD supports Elekta’s linear accelerators — in particular, Versa HD — to meet the growing demand for SIGRT.”

The agreement is now in use in the North American and Mexican markets, with plans in place to eventually expand it to other markets.

C-RAD did not respond for comment.

Rad Oncology Homepage


You Must Be Logged In To Post A Comment